First Quarter 2018 Financial Results to be Announced on May 10 MENLO PARK, Calif. , April 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018 , at 4:00 p.m. PDT . Geron’s stockholders are invited to attend the
MENLO PARK, Calif. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2017 , on Friday, March 16, 2018 , after the market close. Geron’s management will also host a conference call for analysts
Geron regains global rights to imetelstat program Highlights reported for IMerge and IMbark Geron plans to initiate the Phase 3 portion of IMerge Conference call scheduled for 8:00 a.m. ET today MENLO PARK, Calif. , Sept. 27, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced
CEO John A. Scarlett Appointed Chairman Karin Eastham Appointed Lead Independent Director MENLO PARK, Calif. , Dec. 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced changes to the leadership structure of the Company’s Board of Directors.
Data Reporting Median Overall Survival of 29.9 Months in High-Dose Arm Presented at the 60th American Society of Hematology Annual Meeting MENLO PARK, Calif. , Dec. 03, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that results from IMbark, a Phase 2 clinical trial of
Updated Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented MENLO PARK, Calif. , May 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that an abstract describing clinical data regarding the telomerase inhibitor imetelstat has been
Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes and IMbark Primary Analysis in Myelofibrosis to be Presented MENLO PARK, Calif. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that clinical data related to imetelstat, the Company’s
Annual Stockholders Meeting to be Held on May 15, 2018 MENLO PARK, Calif. , May 10, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2018 . First Quarter 2018 Results For the first quarter of 2018, the company reported
Conference Call Scheduled for 8:30 a.m. ET on Monday, March 19 MENLO PARK, Calif. , March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events.
Conference Call Scheduled for July 31 at 4:30 p.m. ET MENLO PARK, Calif. , July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, 2018 . Second Quarter and Year to Date 2018 Results For the second quarter of
